Skip to Main Content

Paper Details

Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.
J Thorac Oncol
227
2020
Author NameAffiliation
Jose A Lopez-Martin12 de Octubre University Hospital and Research Institute (i+12)
Jan H M SchellensNetherlands Cancer Institute
Bo GaoBlacktown Hospital
  • 1 - 3

Datasets

Release 1.2